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Expression of Class I and II Major Histocompatibility Complex
(MHC) Antigens in the Developing CNS
A. Grabowska and L.A. Lampson
Centerfor Neurologic Diseases, Department ofNeurology, Bgham and Women’s Hospital and Harvard
Medical School, BostonMA 02115, USA
The clinical potential of neural transplan-
tation depends upon the feasibility of allogeneic
or xenogeneic transplants, particularly of fetal
tissue. This, in turn, is influenced by donor cell
expression of MHC antigens. MHC expression
in the developing CNS in situ had not been
defined. Here, a panel of antibodies was used to
define MHC expression in the developing rat
embryo.
METHODS
Rat embryos from gestation day 8 were ex-
amined by immunostaining. Multiple antibodies
to MHC class I or b2-microglobulin (b2-m, the
invariant chain of class I molecules) and class II
antigens were used. They included monoclonals
to class I and II, and rabbit antisera to b2-m.
Cryoprotected frozen tissue (optimizing anti-
genicity), and paraffin-embedded tissue
(optimizing morphology) were examined. Im-
munostaining conditions optimizing detection of
cell surface or internal antigen were both used.
Positive controls included brains that had been
injected with cells of known MHC expression
("model tissue"). Monoclonals to leukocyte sub-
sets were used in double-labeling studies, to
further identifyMHC+ cells.
RESULTS
MHC class I and II were detected in the sur-
rounding maternal tissue from the earliest day
examined (day 8), and in the developing embryo
from day 13. MHC expression appeared first in
liver and thymus, and in the connective tissue of
the head. The earliest expression was seen be-
fore the appearance of peripheral T cells. With
time, staining became more widespread. Outside
lymphoid or hematopoietic tissues, a similar pat-
tern of stain was always seen: The strongest stain
was seen in individual cells in the connective
tissue components of the developing organs.
Overall staining of parenchymal cells was not
seen. Developing brain and spinal cord were
similar to other tissues: MHC class I and II were
detected in individual cells in the associated
connective tissues, but were not detected in de-
veloping neural cells.
Based on their distribution, morphologies,
and staining patterns with anti-leukocyte anti-
bodies, the class I+ and class II+ cells were
identified as different subpopulations of
mononuclear phagocytes.
DISCUSSION
In developing brain and spinal cord, MHC
class I and II were detected in associated con-
nective tissues, but not in neural cells. This is
consistent with other studies in which strong
MHC expression was not detected in adult, de-
veloping, or regenerating neural cells in situ/1/.
Taken together, these findings argue against a
non-immunological role for MHC proteins in
neural development, regeneration or homeosta-
sis. This suggests that measures designed to pre-
vent MHC upregulation, as has been seen fol-
lowing surgical trauma or in vitro culture, need
not inhibit growth or function of neural cells.
It is often suggested that lack of detectable
MHC expression is a special property of neural
cells. Our findings support an alternative view,
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thatMHC expression is under regulatory control
in all tissues. Yet another example is seen in
normal adult skeletal muscle, where strong
MHC expression is seen in endothelial cells, but
is not detectable in muscle fibers themselves/2/.
In the rat embryos, the MHC class I+ and
II+ cells outside the lymphoid or hematopoietic
tissues were identified as subpopulations of
mononuclear phagocytes. A well-established
function for MHC+ mononuclear phagocytes in
the adult is to serve as antigen-presenting cells.
Under different conditions, stimulation or toler-
ance may result. The mechanisms for establish-
ment and maintenance of tolerance to extra-
thymic antigens, and of maternal/fetal tolerance,
are still being defined. Their early appearance
leads us to suggest that the MHC+ cells we have
defined may play a role in both contexts. Studies
designed to test this hypothesis will help to re-
veal the cells’ potential function in transplanted
neural tissue as well.
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